Safety and efficacy of a minimally invasive cell sampling device (‘Cytosponge’) in the diagnosis of esophageal pathology

2018 ◽  
Vol 30 (11) ◽  
pp. 1261-1269 ◽  
Author(s):  
Umair Iqbal ◽  
Osama Siddique ◽  
Anais Ovalle ◽  
Hafsa Anwar ◽  
Steven F. Moss
2019 ◽  
Vol 25 (1) ◽  
Author(s):  
Elsayed M. Salih ◽  
Ibrahim Elsotohi ◽  
Hisham Elhelaly ◽  
Mohamed Elsalhy ◽  
Mourad M. Mourad

Abstract Background The goal for using smaller caliber instruments in PNL was to reduce the access-related complications and to decrease morbidity. The objective of this study was to evaluate the safety and efficacy of Chinese minimally invasive percutaneous nephrolithotomy (MIPNL) in the treatment of renal stones ≤ 20 mm. Results Sixty-seven patients completed the study protocol. The mean age was 41.10 ± 13.99 years (range 18–68 years). There were 43 (64%) male and 24 (36%) females. The mean stone size was ranged from 78.5 to 439.6 mm2 (mean ± SD 172.48 ± 69.54 mm2). The overall SFR was (82%). Twelve (18%) needed post-MIPNL auxiliary procedure, in the form of second MIPNL in 3 (4.5%) cases, SWL in 7 (10%), and RIRS in 2 (3%) cases. The intraoperative complication was present in four patients (5%) include bleeding necessitate blood transfusion in one patient (1.5%) and renal collecting system perforation 3 (4.5%). The postoperative complication was urine leakage 5 (7.5) and fever in 6 (9%) of patients. Conclusion Chinese MIPNL is safe and effective method for treatment of renal stone ≤ 20 mm size with satisfactory SFR and low complication rate when SWL failed or contraindicated. It is considered a feasible treatment alternative to standard PNL, in the absence of flexible URS or miniature nephroscope.


2016 ◽  
Vol 1 ◽  
pp. 10-10
Author(s):  
Zhenggen Wu ◽  
Chukai Huang ◽  
Ce Zheng ◽  
Yuqiang Huang ◽  
Wanqi Zhang ◽  
...  

2003 ◽  
Vol 75 (5) ◽  
pp. 1532-1534 ◽  
Author(s):  
William H Ryan ◽  
Jorge Cheirif ◽  
Todd M Dewey ◽  
Syma L Prince ◽  
Michael J Mack

2018 ◽  
Vol 10 (11) ◽  
pp. 327-333 ◽  
Author(s):  
Jennifer Westwood ◽  
Robert Geraghty ◽  
Patrick Jones ◽  
Bhavan P. Rai ◽  
Bhaskar K. Somani

Rezum is a minimally invasive transurethral water vapour therapy for benign prostatic enlargement which uses thermal energy for treatment. The short-term results show it to have good outcomes with a potential for outpatient-based treatment preserving sexual function. This review serves to provide an overview of the technique and evaluate its safety and efficacy.


Sign in / Sign up

Export Citation Format

Share Document